Overview

Shots in the Dark: How Can Clinicians Bridge the Immunization Gaps Widened by the COVID-19 Pandemic?

Roundtable Discussion

Click the"View Activity" button to view this activity.

View Activity

CME/CE is no longer available for this activity

Format

Clinical Commentary

Time to Complete

1.00 hr(s).

Release Date

March 03, 2022

Expires On

March 03, 2023

How can we bridge current immunization gaps further widened by the COVID-19 pandemic? Leading HPV and pneumococcal vaccine experts come together in this round-table discussion to share their experiences and strategies to increase vaccination rates. Additionally, faculty discuss the safety and efficacy data with the latest HPV and pneumococcal conjugate vaccine approvals.

This activity is intended for primary care physicians, advanced practice providers, nurses, and other clinicians involved in immunization of adolescents and adults.

Clinicians (primary care clinicians, advanced practice providers, nurses) involved in ensuring optimal vaccination of HPV and pneumococcal disease need to become more aware of the impact of the COVID-19 pandemic on adolescent and adult immunization rates. These clinicians need to also better understand the current provider-led strategies to improve HPV and pneumococcal vaccination. Finally, these clinicians must also understand the clinical evidence with the latest HPV and pneumococcal approvals and how to incorporate newer HPV and pneumococcal vaccines into appropriate immunization plans.

Upon completion of this activity, participants will be able to:

• Discuss the impact of the COVID-19 pandemic on adolescent and adult immunization rates
• Implement clinician-led strategies to facilitate uptake of HPV and pneumococcal vaccines post-pandemic
• Evaluate the latest safety and efficacy data with the latest pneumococcal conjugate and HPV vaccine approvals
• Incorporate newer pneumococcal conjugate and HPV vaccines into appropriate adult immunization plans as recommended

Sponsored by Cleveland Clinic Center for Continuing Education and the Academy for Continued Healthcare Learning.

Supported by an educational grant from Merck & Co., Inc.

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.

Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker

Laura Dorr Lipold, MD
Director, Primary Care Women’s Health
Section Head, Family Medicine Beachwood Family Health Center
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Assistant Professor of Family Medicine
Department of Family Medicine
Cleveland Clinic
Cleveland, OH

Susan J. Rehm, MD

Department of Infectious Disease

Cleveland Clinic

Cleveland, OH

Amy M. Zack, MD, FAAFP

Family Medicine Physician

Southpointe Medical Center

Vice-Chair of Education

Cleveland Clinic Community Care

Cleveland, OH

Cleveland Clinic Center for Continuing Education requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.

The following financial relationships have been provided:

Susan Rehm, MD

Advisor or review panel participant: Pfizer

Teaching and Speaking: Merck

Ownership interest: Amgen; Eli Lilly; Medtronic; Merck; Pfizer; Roche

The following faculty have indicated they have nothing to disclose:

Laura Lipold, MD

Amy Zack, MD, FAAFP

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

Cleveland Clinic Center for Continuing Education and ACHL staff involved with the planning, development, and review of this activity have no relevant affiliations or financial relationships to disclose.

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity, and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions, contact Katie Hacias at khacias@achlcme.org

ACCREDITATION
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION
• American Medical Association (AMA) Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• American Nurses Credentialing Center (ANCC) Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 1.0 ANCC contact hour.
• Certificate of Participation A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.

Katie Hacias
khacias@achlcme.org
Phone: (773)714-0705 ext. 159

Overview

Shots in the Dark: How Can Clinicians Bridge the Immunization Gaps Widened by the COVID-19 Pandemic?

Program Description

Intended Audience

Activity Purpose

Learning Objectives

Provider Information

Supporter Information

Hardware and Software Requirement

Faculty

Faculty Disclosure

Staff Disclosure

Disclaimer

Method of Participation

Accreditation and Credit Designation

Program Manager

Related Activities